O

Ocugen
D

OCGN

0.95700
USD
0.04
(4.03%)
مغلق
حجم التداول
8,818
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
279,473,949
أصول ذات صلة
A
ABUS
0.05000
(1.57%)
3.24000 USD
A
ALT
-0.14000
(-2.86%)
4.75000 USD
A
AUPH
0.09000
(1.20%)
7.57000 USD
BNTX
BNTX
1.570
(1.45%)
109.800 USD
I
INO
-0.71500
(-33.49%)
1.42000 USD
MRNA
MRNA
0.195
(0.64%)
30.480 USD
N
NVAX
0.04000
(0.59%)
6.79000 USD
V
VIR
0.05500
(1.02%)
5.47000 USD
V
VXRT
-0.01110
(-2.53%)
0.42750 USD
المزيد
الأخبار المقالات

العنوان: Ocugen

القطاع: Healthcare
الصناعة: Biotechnology
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").